Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
In addition, Semaglutide, another long-acting GLP-1 RA, has demonstrated superior efficacy in lowering blood glucose levels and reducing body weight compared to placebo or Liraglutide
Apr 28th, 2026 How Retatrutide Impacts Weight Loss and Metabolism Retatrutide is an investigational triple agonist targeting GIP, GLP-1, and glucagon receptors that has shown significant weight loss and metabolic benefits in trials, but it is not yet FDA-approved and remains available only in clinical studies
Finally, SGLT2 inhibitors modulate the composition of the gut microbiota
PlexusDx compounded GLP-1 therapies deliver affordable access immediately, with semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan and tirzepatide at $289/month, without requiring patents to expire or generics to launch
US$ 20.79
US$ 23.16
US$ 20.92
US$ 25.43
US$ 21.61
US$ 29.30
US$ 24.55
US$ 28.24
US$ 27.96
US$ 23.77
US$ 24.07
